NASDAQ · Analyst Forecast

Veracyte, Inc. (VCYT) Stock Forecast & Price Target

$24.23 NASDAQ: VCYT Market Cap $1.96B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Veracyte, Inc. (VCYT), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Veracyte, Inc., analysts forecast revenue rising from $511.67M in 2025 to $928.61M in 2030; the average estimate for 2030 earnings per share is $2.17; with published estimates ranging from $2.12 to $2.26; 8 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$24.23
Consensus targetThe average of the price targets analysts have published.$54.14
Median targetThe middle target, less affected by a single outlier.$54.00
Highest targetThe most optimistic published target.$65.00
Lowest targetThe most pessimistic published target.$44.00
Difference from priceHow far the consensus target sits from today’s price.+123.4%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$501.35M$511.67M$527.07M7
2026$590.10M$591.01M$591.91M7
2027$633.57M$634.33M$635.09M8
2028$649.13M$692.18M$755.98M8
2029$820.41M$837.31M$862.50M6
2030$909.87M$928.61M$956.55M6

Earnings per share forecast

YearLowAverageHighAnalysts
2025$1.63$1.66$1.707
2026$1.88$1.92$1.967
2027$1.51$1.57$1.638
2028$1.40$1.72$1.918
2029$2.02$2.07$2.156
2030$2.12$2.17$2.266

Veracyte, Inc. (VCYT) forecast — frequently asked questions

What is the analyst price target for Veracyte, Inc.?

Analysts covering Veracyte, Inc. (VCYT) have a consensus price target of $54.14, 123.4% above the current price of $24.23. Published targets range from $44.00 to $65.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Veracyte, Inc.'s earnings?

The average analyst estimate for Veracyte, Inc. (VCYT) earnings per share in 2030 is 2.17, with individual estimates between 2.12 and 2.26.

How much revenue is Veracyte, Inc. expected to make?

Analysts forecast Veracyte, Inc. (VCYT) revenue of $928.61M in 2030, based on 6 published estimates.

How many analysts cover VCYT?

8 analysts contribute estimates for Veracyte, Inc. (VCYT). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Diagnostics & Research stocks

TMO forecastDHR forecastIDXX forecastA forecastWAT forecastIQV forecastNTRA forecastMTD forecastILMN forecastLH forecastAll Medical - Diagnostics & Research stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.